[HTML] frontiersin.org

[HTML][HTML] Discovery stories of RET fusions in lung cancer: a mini-review

K Takeuchi - Frontiers in Physiology, 2019 - frontiersin.org
In 2004, a chemical inhibitor of the kinase activity of EGFR was reported to be effective in a
subset of lung cancer patients with activating somatic mutations of EGFR. It remained …
被引用次数：45 相关文章
[HTML] nih.gov

[HTML][HTML] Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review

K Takeuchi - Frontiers in Physiology, 2019 - ncbi.nlm.nih.gov
In 2004, a chemical inhibitor of the kinase activity of EGFR was reported to be effective in a
subset of lung cancer patients with activating somatic mutations of EGFR. It remained …

Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review.

K Takeuchi - Frontiers in Physiology, 2019 - europepmc.org
In 2004, a chemical inhibitor of the kinase activity of EGFR was reported to be effective in a
subset of lung cancer patients with activating somatic mutations of EGFR. It remained …

Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review

K Takeuchi - Frontiers in physiology, 2019 - pubmed.ncbi.nlm.nih.gov
In 2004, a chemical inhibitor of the kinase activity of EGFR was reported to be effective in a
subset of lung cancer patients with activating somatic mutations of EGFR. It remained …

Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review.

K Takeuchi - Frontiers in Physiology, 2019 - europepmc.org
In 2004, a chemical inhibitor of the kinase activity of EGFR was reported to be effective in a
subset of lung cancer patients with activating somatic mutations of EGFR. It remained …